WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Stock Ownership - Who owns Arbutus Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arbutus Biopharma Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Keith S. ManchesterDirector2024-08-148,846$3.69
$32.63kSell
Keith S. ManchesterDirector2024-08-1454,915$0.56
$30.75kBuy
David C. HastingsChief Financial Officer2024-02-029,593$2.31
$22.18kSell
Michael J. McElhaughInterim President CEO2024-02-0210,164$2.31
$23.50kSell
Karen SimsChief Medical Officer2024-02-024,358$2.31
$10.08kSell
Michael J. SofiaChief Scientific Officer2024-02-029,982$2.31
$23.08kSell

1 of 1

ABUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABUS insiders and whales buy or sell their stock.

ABUS Shareholders

What type of owners hold Arbutus Biopharma Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Roivant Sciences Ltd20.58%38,847,462$150.73MInsider
Dexxon Holdings Ltd16.97%32,027,080$124.27MInsider
Morgan Stanley11.10%20,960,268$81.33MInstitution
Vivek Ramaswamy8.51%16,068,455$62.35MInsider
Dexcel Pharma Technologies Ltd8.48%16,013,540$62.13MInsider
Andrew Lo8.48%16,013,540$62.13MInsider
Patrick MacHado8.48%16,013,540$62.13MInsider
Qvt Associates GP LLC8.48%16,013,540$62.13MInsider
Rose Sharon Shabet8.48%16,013,540$62.13MInsider
Svf Investments Uk Ltd8.48%16,013,540$62.13MInsider

1 of 3

ABUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABUS28.74%71.26%Net BuyingNet Buying
IMNM79.57%10.38%Net BuyingNet Buying
TNGX61.49%38.51%Net SellingNet Selling
ADPT62.85%37.15%Net SellingNet Selling
ABCL38.80%45.16%Net BuyingNet Buying
View Top Biotech Stocks

Arbutus Biopharma Stock Ownership FAQ

Who owns Arbutus Biopharma?

Arbutus Biopharma (NASDAQ: ABUS) is owned by 51.04% institutional shareholders, 126.59% Arbutus Biopharma insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Arbutus Biopharma shareholder, owning 38.85M shares representing 20.58% of the company. Roivant Sciences Ltd's Arbutus Biopharma shares are currently valued at $150.73M.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.